The Food and Drug Administration on Wednesday approved Gilead's twice-yearly antiviral injection for preventing HIV — a milestone that the company and some experts say could help bring the world ...
Hosted on MSN
South Africa to roll out Lenacapavir HIV prevention injection in 2024, targeting key populations
A six-month HIV prevention injection, Lenacapavir, will soon be available in South Africa Health officials say the program targets all HIV-negative individuals, including men, women, and key ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results